Tryptamine to plug $6M placement funding into acceleration of IV-infused psilocybin treatment trials
Tryptamine Therapeutics Ltd (ASX:TYP) is aiming to raise $6 million through a…
Tryptamine Therapeutics Limited (ASX:TYP)
About Tryptamine Therapeutics Limited
Key Information
TYP In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 22/11/2024 | First patient dosed in Phase 1b study into obese subjects | 246.9KB | 1.0K |
| 19/11/2024 | Price Sensitive PS Phase 1b determines optimal parameters for TRP-8803 use | 410.4KB | 3.1K |
| 12/11/2024 | Application for quotation of securities - TYP | 17.39KB | 279 |
| 12/11/2024 | Proposed issue of securities - TYP | 16.92KB | 251 |
| 12/11/2024 | Prospectus | 524.08KB | 3.7K |
| 08/11/2024 | Initial Director's Interest Notice - DT | 3.42KB | 393 |
| 08/11/2024 | Final Director's Interest Notice - CB | 3.62KB | 253 |
| 08/11/2024 | Final Director's Interest Notice - PM | 203.71KB | 264 |